PROMUS® 2.25 mm Everolimus-Eluting
Coronary Stent System
Not All Olimus Stents Are Created Equal…for Small Vessels
The right olimus from the right partner
The PROMUS 2.25 mm Stent System combines a highly deliverable platform with an effective drug and polymer design to provide an optimal olimus, from a partner you trust.
Effective Drug and Polymer Design
- Everolimus is highly lipophilic1
- Low drug load2
- Thin, fluorinated copolymer matrix for controlled drug release (100% drug elution in 120 days)3
Exceptional Deliverability
- Thin 0.0032" cobalt chromium struts and open cell design allow for excellent flexibility and conformability.
- Low 0.041" stent profile for enhanced deliverability2,3
Excellent Angiographic and Clinical Results4
The SPIRIT Small Vessel (SV) Registry demonstrates the safety and efficacy of the Xience nano™ (PROMUS 2.25 mm) Stent.
 |
 |
Want to learn more about the PROMUS® Everolimus-Eluting Coronary Stent Series?
Visit our product section to view the full line of PROMUS Stents
Learn More
Prior to use, please see the complete "Directions for Use" for more information on Indications, Contraindications, Warnings, Precautions, Adverse Events, and Operator's Instructions
View PROMUS Stent Series Presecriptive Information »
Print This Page
REFERENCES
1 Grube E, Sonoda S, Ikeno F, et al. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation. 2004;109:2168-2171.
2 PROMUS 2.25 mm Stent Instructions for Use (IFU).
3 Data on file at Boston Scientific Corporation.
4 PROMUS Instructions for Use.
PROMUS 2.25 mm is a private-labeled Xience NANO™ Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific Corporation. Xience NANO is a trademark of Abbott Laboratories group of companies.
90677570